http://rdf.ncbi.nlm.nih.gov/pubchem/reference/13182062

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't|Research Support, U.S. Gov't, P.H.S.
endingPage 237
issn 0167-6806
1573-7217
issueIdentifier 3
pageRange 225-237
publicationName Breast Cancer Research and Treatment
startingPage 225
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_27986060ebaa0ddc226f63b2c7c69287
bibliographicCitation Holst-Hansen C, Low JA, Stephens RW, Johnson MD, Carmeliet P, Frandsen TL, Brünner N, Dickson RB. Increased stromal expression of murine urokinase plasminogen activator in a human breast cancer xenograft model following treatment with the matrix metalloprotease inhibitor, batimastat. Breast Cancer Res Treat. 2001 Aug;68(3):225–37. doi: 10.1023/a:1012217820507. PMID: 11727959.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_73af2dd5bffe362bd342ff09e7454aae
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7961-1821
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_daccd192f333e528f50fb2f9f95fb2fe
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_88fd95b225d1fbc644958e70bb931932
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b8b6f41fbf42ce563618e3762e4cf63f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_99976cab57b68545984a1f5b9d1f18dd
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fd1e7d7fd6eb20289aceb02d871f4c1b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bacea6e12f13ca0f9c9682bd9d602e76
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_16eee00076c3fe5ccb6c55953e46eb21
date 200108
identifier https://pubmed.ncbi.nlm.nih.gov/11727959
https://doi.org/10.1023/a:1012217820507
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1254
https://portal.issn.org/resource/ISSN/1573-7217
https://portal.issn.org/resource/ISSN/0167-6806
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
https://scigraph.springernature.com/
title Increased stromal expression of murine urokinase plasminogen activator in a human breast cancer xenograft model following treatment with the matrix metalloprotease inhibitor, batimastat
discusses http://id.nlm.nih.gov/mesh/M0129180
http://id.nlm.nih.gov/mesh/M0018574
http://id.nlm.nih.gov/mesh/M0019167
http://id.nlm.nih.gov/mesh/M0013502
http://id.nlm.nih.gov/mesh/M0216168
http://id.nlm.nih.gov/mesh/M0513791
http://id.nlm.nih.gov/mesh/M0027090
http://id.nlm.nih.gov/mesh/M0431189
http://id.nlm.nih.gov/mesh/M0017845
http://id.nlm.nih.gov/mesh/M0021371
http://id.nlm.nih.gov/mesh/M0016544
http://id.nlm.nih.gov/mesh/M0016994
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8153
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7102
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.4.21.73
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_0943bfb20a0e8ebccd479b74c7b652df
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_89d708279e197fec68596fc46bc48c90
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5362422

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136197901
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127654813

Total number of triples: 53.